{"result": "(\"entity\"<|>ENGL J MED<|>ORGANIZATION<|>The New England Journal of Medicine, a peer-reviewed medical journal that publishes research and clinical studies in the field of medicine.)\n##\n(\"entity\"<|>INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES<|>ORGANIZATION<|>A professional organization that provides guidelines and recommendations for the management of diabetes in children and adolescents.)\n##\n(\"entity\"<|>CHARCOT ARTHROPATHY<|>EVENT<|>A condition characterized by joint damage due to neuropathy, often associated with diabetes, requiring careful diagnosis and management.)\n##\n(\"entity\"<|>SEQUEIRA W<|>PERSON<|>An author who has contributed to the literature on neuropathic joint conditions, particularly in the context of diabetes.)\n##\n(\"entity\"<|>DIABETES MELLITUS<|>EVENT<|>A chronic condition that affects how the body processes blood sugar (glucose), often leading to complications such as neuropathy and joint issues.)\n##\n(\"entity\"<|>PEDIATRIC DIABETES<|>EVENT<|>A field of medicine focused on the diagnosis and management of diabetes in children and adolescents.)\n##\n(\"relationship\"<|>INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES<|>CHARCOT ARTHROPATHY<|>The International Society for Pediatric and Adolescent Diabetes provides guidelines relevant to the management of conditions like Charcot arthropathy in diabetic patients<|>7)\n##\n(\"relationship\"<|>SEQUEIRA W<|>CHARCOT ARTHROPATHY<|>Sequeira W has published research on Charcot arthropathy, contributing to the understanding of this condition<|>8)\n##\n(\"relationship\"<|>DIABETES MELLITUS<|>CHARCOT ARTHROPATHY<|>Charcot arthropathy is a complication that can arise from diabetes mellitus, linking the two conditions<|>9)\n##\n(\"relationship\"<|>ENGL J MED<|>INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES<|>The New England Journal of Medicine publishes research and guidelines that may include contributions from the International Society for Pediatric and Adolescent Diabetes<|>6)\n##\n(\"relationship\"<|>DIABETES MELLITUS<|>PEDIATRIC DIABETES<|>Pediatric diabetes is a subset of diabetes mellitus, focusing on its impact on children and adolescents<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Engl J Med. 2015;372(6):546-54.\n- Palmer BF, Clegg DJ. Electrolyte and Acid-Base Disturbances in Patients with Diabetes Mellitus. N Engl J Med. 2015;373(6):548-59.\n- Wolfsdorf JI, Allgrove J, Craig ME, Edge J, Glaser N, Jain V, et al; International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014; 15 Suppl 20:154-79.\n\n## 2.6 Casos clínicos. Caso clínico 3\n\n## 82 ¿Cuál es el diagnóstico más probable en esta situación?\n\nA. Gota.\nB. Pie de Charcot.\nC. Isquemia aguda.\nD. Ninguna de las anteriores.\n\n## COMENTARIO\n\nSe debe realizar una consideración especial y un estudio exhaustivo cuando los pacientes con neuropatía presentan un inicio agudo de pie o tobillo inflamado, enrojecido y caliente, y debe excluirse la neuroartropatía de Charcot.\n\nEl diagnóstico precoz y el tratamiento de la neuroartropatía de Charcot es la mejor manera de prevenir las deformidades que aumentan el riesgo de ulceración y amputación.\n\n### Referencias:\n- Sequeira W. The neuropathic joint. Clin Exp Rheumatol. 1994 May-Jun;12(3):325-37.\n\n## 83 Qué prueba diagnóstica es la inicialmente recomendada en este caso:\n\nA. Tomografía axial computarizada.\nB. Radiografía simple.\nC. Resonancia magnética nuclear.\nD. Gammagrafía con leucocitos marcados.\n---\nDIABETES 2\n\nCOMENTARIO\n\nEl diagnóstico se basa en la presencia de síntomas característicos y hallazgos físicos y radiográficos, que dependen de la etapa de la enfermedad. Se deben excluir otras afecciones que pueden simular una artropatía neuropática, como celulitis, osteomielitis, artritis séptica, gota, osteoartritis y artritis inflamatoria.\n\nSe deben obtener radiografías simples de las articulaciones afectadas. En pacientes con radiografías que son normales o no concluyentes, se debe obtener un estudio de resonancia magnética nuclear (RMN) sin contraste. Si bien una segunda radiografía obtenida varias semanas después de la presentación puede aclarar el diagnóstico de artropatía neuropática temprana aguda, el uso de la radiografía simple por sí sola inevitablemente produce retrasos indeseables en el diagnóstico y el tratamiento.\n\nLa escintigrafía ósea se usa a veces como alternativa a la RMN, particularmente cuando existe una disponibilidad limitada de esta técnica, y puede utilizarse en pacientes cuando la presencia de metal impide la resonancia. En presencia de cambios isquémicos regionales o difusos se preferiría la RMN.\n\nReferencias:\n• Sequeira W. The neuropathic joint. Clin Exp Rheumatol. 1994 May-Jun;12(3):325-37.\n\n## 84 El tratamiento de primera línea en este caso será:\n\nA. Cirugía correctora con artrodesis.\nB. Inmovilización con descarga total de la extremidad.\nC. Tratamiento con antibiótico parenteral.\nD. Administración de bisfosfonatos.\n\nCOMENTARIO\n\nEl tratamiento debe ser individualizado y llevado a cabo por un equipo multidisciplinar con experiencia en esta afección, incluidos los expertos médicos en enfermedades articulares y diabetes, y especialistas en cirugía de pie y tobillo y podología.\n\nLa experiencia en terapia física también puede ser útil con la movilidad y los dispositivos para caminar. En la etapa activa aguda de la artropatía neuropática diabética, la descarga del pie es la intervención más importante, y generalmente se realiza mediante el uso de un yeso de contacto total no removible. Los enfoques alternativos incluyen el uso de muletas o una silla de ruedas.\n\nReferencias:\n• Petrova NL, Edmonds ME. Medical management of Charcot arthropathy. Diabetes Obes Metab. 2013;15(3):193-7.\n\n## 85 Si el tratamiento inicial no es efectivo, la siguiente línea de tratamiento será:\n\nA. Administración de bisfosfonatos.\nB. Estimulación de remodelación ósea con ultrasonidos.\nC. Tratamiento antibiótico parenteral.\nD. Cirugía correctora con artrodesis.\n\nCOMENTARIO\n\nEl papel de los bisfosfonatos y la calcitonina en la neuroartropatía aguda de Charcot sigue siendo incierto.\n\nLos pacientes con enfermedad crónica y lesión articular que no responden adecuadamente a otras intervenciones deben ser remitidos a un cirujano ortopédico con experiencia en el tratamiento de la artropatía neuropática diabética para evaluar los riesgos y beneficios individuales de una estabilización quirúrgica u otros procedimientos. El objetivo del tratamiento en pacientes con más enfermedades crónicas\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}